Dose-Escalated Radiation Alone or in Combination With Short-Term Total Androgen Suppression for Intermediate-Risk Prostate Cancer: Patient-Reported Outcomes From NRG/Radiation Therapy Oncology Group 0815 Randomized Trial.
J Clin Oncol
; 41(17): 3217-3224, 2023 06 10.
Article
in En
| MEDLINE
| ID: mdl-37104723
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostatic Neoplasms
/
Androgens
Type of study:
Clinical_trials
/
Etiology_studies
/
Risk_factors_studies
Aspects:
Patient_preference
Limits:
Humans
/
Male
Language:
En
Journal:
J Clin Oncol
Year:
2023
Document type:
Article
Country of publication: